Full Fed. Circ. Urged To Review Axing Of DNA Test Patent
Major industry groups, professors and corporations filed a raft of amicus briefs last week urging the full Federal Circuit to rehear a decision that Sequenom Inc.'s fetal DNA test patent is...To view the full article, register now.
Already a subscriber? Click here to view full article